WallStreetZenWallStreetZen

NASDAQ: CGTX
Cognition Therapeutics Inc Stock Ownership - Who owns Cognition Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cognition Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John Brendan DoyleChief Financial Officer2026-05-018,567$1.28
$10.97kSell
Anthony CaggianoChief Medical Officer2026-04-1610,000$1.11
$11.10kBuy
John Brendan DoyleChief Financial Officer2026-04-1610,000$1.13
$11.30kBuy
Lisa RicciardiCEO President2026-04-169,175$1.10
$10.09kBuy
John Brendan DoyleChief Financial Officer2026-02-151,560$1.12
$1.75kSell
Anthony CaggianoChief Medical Officer2026-02-154,680$1.12
$5.24kSell
Lisa RicciardiCEO President2026-02-155,850$1.12
$6.55kSell
Lisa RicciardiCEO President2026-02-0451,704$1.03
$53.26kSell
John Brendan DoyleChief Financial Officer2026-02-0426,921$1.03
$27.73kSell
Anthony CaggianoChief Medical Officer2026-02-0426,919$1.03
$27.73kSell

1 of 2

CGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CGTX insiders and whales buy or sell their stock.

CGTX Shareholders

What type of owners hold Cognition Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aaron Gl Fletcher10.83%10,301,947$7.12MInsider
Leslie W. Kreis6.68%6,356,377$4.39MInsider
Bios Memory Spv I LP4.11%3,912,841$2.70MInsider
Ogden Cap Associates LLC2.32%2,210,377$1.53MInsider
Lisa Ricciardi1.85%1,754,702$1.21MInsider
Anthony Caggiano0.92%874,906$604.56kInsider
John Brendan Doyle0.65%618,942$427.69kInsider
Bios Clinical Opportunity Fund LP0.53%500,095$345.57kInsider
Mark H. Breedlove0.43%412,050$284.73kInsider
Peggy Wallace0.12%111,461$77.02kInsider

1 of 3

CGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CGTX0.02%28.70%Net Selling
FBIO0.02%49.61%Net BuyingNet Buying
CLNN0.01%99.99%Net BuyingNet Buying
CNXU0.00%56.30%Net BuyingNet Buying
MAIA0.02%7.36%Net BuyingNet Buying
View Top Biotech Stocks

Cognition Therapeutics Stock Ownership FAQ

Who owns Cognition Therapeutics?

Cognition Therapeutics (NASDAQ: CGTX) is owned by 0.02% institutional shareholders, 28.70% Cognition Therapeutics insiders, and 71.28% retail investors. Aaron Gl Fletcher is the largest individual Cognition Therapeutics shareholder, owning 10.30M shares representing 10.83% of the company. Aaron Gl Fletcher's Cognition Therapeutics shares are currently valued at $6.90M.

If you're new to stock investing, here's how to buy Cognition Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.